Morgan D. Fullerton - Concepedia

Author

Morgan D. Fullerton

McMaster University ORCID

Also Known As

Fullerton, Morgan D., M. D. Fullerton, Morgan D Fullerton, Morgan D. Fullerton, Morgan Fullerton, Morgan D. Fullerton

Publications

6.1K

Citations

H-Index

Concepts

All Affiliations

McMaster University University of Ottawa Institute of Infection and Immunity The University of Melbourne St Vincents Institute of Medical Research

About

Morgan D. Fullerton is an author at McMaster University specializing in medicine, physiology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	2.6K
2	Health Sciences	11	11	1.4K
3	Natural Sciences	3	3	164
4	Public Health	1	1	15
5	Applied Physiology	1	1	41

Morgan D. Fullerton

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin Morgan D. Fullerton, Sandra Galić, Katarina Marcinko, Nature Medicine	2013	852
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase Simon A. Hawley, Morgan D. Fullerton, Fiona A. Ross, Science Signal TransductionOxysterolBiochemistryAmp-activated Protein KinaseMedicine	2012	723
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis Justin D. Crane, Rengasamy Palanivel, Emilio P. Mottillo, Nature Medicine ObesityMetabolic SyndromeEnergy HomeostasisBody CompositionBiochemistry	2014	474
MicroRNA-33–dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis Mireille Ouimet, Hasini Ediriweera, Uma Mahesh Gundra, Journal of Clinical Investigation	2015	382
Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity Sandra Galić, Morgan D. Fullerton, Jonathan D. Schertzer, Journal of Clinical Investigation Metabolic DisorderImmunologyAmpk β1Metabolic RemodelingAdipokines	2011	328
NOD1 Activators Link Innate Immunity to Insulin Resistance Jonathan D. Schertzer, Akhilesh K. Tamrakar, João G. Magalhães, Diabetes	2011	241
Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4 Joseph F. Cavallari, Morgan D. Fullerton, Brittany M. Duggan, Cell Metabolism Metabolic SyndromeBiochemistryMedicineMetabolic RegulationMetabolism	2017	237
Defective <scp>NOD</scp> 2 peptidoglycan sensing promotes diet‐induced inflammation, dysbiosis, and insulin resistance Emmanuel Denou, Karine Lolmède, Lucile Garidou, EMBO Molecular Medicine	2015	185
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity Rebecca J. Ford, Morgan D. Fullerton, Stephen L. Pinkosky, Biochemical Journal Inhibit LipogenesisFatty Liver DiseaseInsulin SignalingMetabolic SyndromeMolecular Pharmacology	2015	152
Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity Sebastian B. Jørgensen, Hayley M. O’Neill, Lykke Sylow, Diabetes ImmunologyAdipokinesInsulin SignalingObesityMetabolic Syndrome	2012	140

Page 1